Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].
Journal: Journal of the neurological sciences
Published: May 13, 2026
Long-Term Safety and Efficacy of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE/ADHERE+ Trial Interim Analysis.
Journal: Journal of the peripheral nervous system : JPNS
Published: March 19, 2026
Expanding the Clinical and Molecular Spectrum of TUBB2B Through Distinct Variants Identified Across Multiple Families.
Journal: medRxiv : the preprint server for health sciences
Published: January 08, 2026
Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.
Journal: Journal of the neurological sciences
Published: December 15, 2025
CEP76 impairment at the centrosome-cilium interface contributes to a spectrum of ciliopathies.
Journal: Science advances
Published: October 17, 2025
Uncovering phenotypic expansion in AXIN2-related disorders through precision animal modeling.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 12, 2025
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.
Journal: Therapeutic advances in neurological disorders
Published: August 18, 2025
Development of RS1-specific ACMG/AMP variant classification criteria with pilot variant curation.
Journal: Human genetics
Published: June 20, 2025
Chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) chase prey around obstacles in virtual environments.
Journal: Journal of comparative psychology (Washington, D.C. : 1983)
Published: March 24, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Last Updated: 09/26/2026